Epilepsy affects millions worldwide and can limit everyday activities. Some forms arise from genetic mutations in GABAA_AA​ receptors, disrupting the balance between brain excitation and inhibition. This research examines how these mutations reduce receptor levels and explores drug strategies to restore inhibition, paving the way for improved epilepsy treatments.

A researcher explains how anatomical differences in the vagus nerve drive inconsistent outcomes in epilepsy treatment. By dissecting and 3D-mapping human vagus nerves, the team reveals major left–right differences, enabling more precise electrode placement. This work promises safer, more effective nerve stimulation therapies for epilepsy and other diseases.

Electrical signals in the body depend on ion channels that regulate salt movement across cell membranes. When these channels malfunction, diseases like epilepsy and heart arrhythmias can occur. This research decodes how faulty ion channels work, revealing potassium-based mechanisms that could restore electrical signaling and guide new therapies.

SLC13A5 citrate transport disorder causes severe neonatal seizures due to disrupted citrate balance in the brain. This research uses mouse models to show excess citrate worsens seizures and explores gene replacement therapy to restore transporter function. Early results show reduced seizures, with human clinical trials beginning soon.